Influence of the Superficial Inferior Epigastric System in Deep Inferior Epigastric Perforator (DIEP) Flaps

NCT01464970 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2012-05-14

No results posted yet for this study

Summary

The purpose of this study is to determine in-vivo the effects the contralateral superficial inferior epigastric vascular system has on the perfusion of Zone IV of deep inferior epigastric perforator flaps.

Conditions

Interventions

PROCEDURE

Both Superficial Inferior Artery and Vein Clamped

Perfusion assessed in Zone IV of the DIEP flap whilst both the contralateral Superficial Inferior Epigastric Artery and Vein are clamped

PROCEDURE

Superficial Inferior Epigastric Vessels both unclamped

Perfusion assessed in Zone IV of the DIEP flap whilst both the contralateral Superficial Inferior Epigastric Artery and Vein are unclamped

PROCEDURE

SIE Artery Unclamped, Vein Clamped

Perfusion assessed in Zone IV of the DIEP flap whilst the contralateral Superficial Inferior Epigastric Artery is unclamped and the Vein is clamped

PROCEDURE

SIE Artery clamped, Vein unclamped

Perfusion assessed in Zone IV of the DIEP flap whilst the contralateral Superficial Inferior Epigastric Artery is clamped and the Vein is unclamped

Sponsors & Collaborators

  • Canniesburn Research Trust

    collaborator UNKNOWN
  • NHS Greater Glasgow and Clyde

    lead OTHER

Principal Investigators

  • Adam Gilmour, MBChB, MRCS (Ed) · Canniesburn Plastic Surgery Unit

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-12-31
Primary Completion
2012-12-31
Completion
2012-12-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01464970 on ClinicalTrials.gov